These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 29248888)
1. Genetics and genomics of breast fibroadenomas. Loke BN; Md Nasir ND; Thike AA; Lee JYH; Lee CS; Teh BT; Tan PH J Clin Pathol; 2018 May; 71(5):381-387. PubMed ID: 29248888 [TBL] [Abstract][Full Text] [Related]
2. Genomic landscapes of breast fibroepithelial tumors. Tan J; Ong CK; Lim WK; Ng CC; Thike AA; Ng LM; Rajasegaran V; Myint SS; Nagarajan S; Thangaraju S; Dey S; Nasir ND; Wijaya GC; Lim JQ; Huang D; Li Z; Wong BH; Chan JY; McPherson JR; Cutcutache I; Poore G; Tay ST; Tan WJ; Putti TC; Ahmad BS; Iau P; Chan CW; Tang AP; Yong WS; Madhukumar P; Ho GH; Tan VK; Wong CY; Hartman M; Ong KW; Tan BK; Rozen SG; Tan P; Tan PH; Teh BT Nat Genet; 2015 Nov; 47(11):1341-5. PubMed ID: 26437033 [TBL] [Abstract][Full Text] [Related]
4. MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression. Tan WJ; Chan JY; Thike AA; Lim JC; Md Nasir ND; Tan JS; Koh VC; Lim WK; Tan J; Ng CC; Rajasegaran V; Nagarajan S; Bay BH; Teh BT; Tan PH J Clin Pathol; 2016 Oct; 69(10):858-65. PubMed ID: 27056456 [TBL] [Abstract][Full Text] [Related]
5. Frequent MED12 mutations in phyllodes tumours of the breast. Yoshida M; Sekine S; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Ochiai A Br J Cancer; 2015 May; 112(10):1703-8. PubMed ID: 25839987 [TBL] [Abstract][Full Text] [Related]
6. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis. Pfarr N; Kriegsmann M; Sinn P; Klauschen F; Endris V; Herpel E; Muckenhuber A; Jesinghaus M; Klosterhalfen B; Penzel R; Lennerz JK; Weichert W; Stenzinger A Genes Chromosomes Cancer; 2015 Jul; 54(7):444-52. PubMed ID: 25931199 [TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis. Lien HC; Huang CS; Yang YW; Jeng YM Histopathology; 2016 Feb; 68(3):433-41. PubMed ID: 26109290 [TBL] [Abstract][Full Text] [Related]
8. DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast. Huang KT; Dobrovic A; Yan M; Karim RZ; Lee CS; Lakhani SR; Fox SB Breast Cancer Res Treat; 2010 Nov; 124(2):555-65. PubMed ID: 20563638 [TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing. Mishima C; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S Breast Cancer Res Treat; 2015 Jul; 152(2):305-12. PubMed ID: 26093648 [TBL] [Abstract][Full Text] [Related]
11. MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast. Piscuoglio S; Murray M; Fusco N; MarchiĆ² C; Loo FL; Martelotto LG; Schultheis AM; Akram M; Weigelt B; Brogi E; Reis-Filho JS Histopathology; 2015 Nov; 67(5):719-29. PubMed ID: 25855048 [TBL] [Abstract][Full Text] [Related]
12. Stromal da Silva EM; Beca F; Sebastiao APM; Murray MP; Silveira C; Da Cruz Paula A; Pareja F; Wen HY; D'Alfonso TM; Edelweiss M; Weigelt B; Brogi E; Reis-Filho JS; Zhang H J Clin Pathol; 2022 Feb; 75(2):133-136. PubMed ID: 33376197 [TBL] [Abstract][Full Text] [Related]
13. Genomic characterisation of breast fibroepithelial lesions in an international cohort. Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343 [TBL] [Abstract][Full Text] [Related]
15. MED12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions. Hu Y; Li G; Wang L; Zhang L; Guan J; Wang J Pathol Int; 2021 Dec; 71(12):814-822. PubMed ID: 34597441 [TBL] [Abstract][Full Text] [Related]
16. MED12 exon 2 mutations in phyllodes tumors of the breast. Nagasawa S; Maeda I; Fukuda T; Wu W; Hayami R; Kojima Y; Tsugawa K; Ohta T Cancer Med; 2015 Jul; 4(7):1117-21. PubMed ID: 25865354 [TBL] [Abstract][Full Text] [Related]
17. TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast. Yoshida M; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Hiraoka N; Sekine S Br J Cancer; 2015 Oct; 113(8):1244-8. PubMed ID: 26355235 [TBL] [Abstract][Full Text] [Related]
18. A novel genomic panel as an adjunctive diagnostic tool for the characterization and profiling of breast Fibroepithelial lesions. Sim Y; Ng GXP; Ng CCY; Rajasegaran V; Wong SF; Liu W; Guan P; Nagarajan S; Ng WY; Thike AA; Lim JCT; Nasir NDBM; Tan VKM; Madhukumar P; Yong WS; Wong CY; Tan BKT; Ong KW; Teh BT; Tan PH BMC Med Genomics; 2019 Oct; 12(1):142. PubMed ID: 31647027 [TBL] [Abstract][Full Text] [Related]
19. A Diagnostic Approach to Fibroepithelial Breast Lesions. Tan BY; Tan PH Surg Pathol Clin; 2018 Mar; 11(1):17-42. PubMed ID: 29413655 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis for loss of heterozygosity in primary and recurrent phyllodes tumor and fibroadenoma of breast using single nucleotide polymorphism arrays. Wang ZC; Buraimoh A; Iglehart JD; Richardson AL Breast Cancer Res Treat; 2006 Jun; 97(3):301-9. PubMed ID: 16791486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]